<p>(A) Analysis the half-life of EGFR protein level in 100 µg/ml cycloheximide treated CL1-5 cells with or without 10 µM curcumin by Western blotting. (B) Western blotting analysis revealed that MG132 recover the EGFR level of the curcumin-affected EGFR protein depletion. β-actin used as the internal control and the numbers below the row of the EGFR indicate the densitometric values normalized with the relative β-actin value. (C) Detection of ubiquitin (Ub) levels by immunoprecipitation of EGFR in CL1-5, A549 and H1975 cells showed the elevation of poly-Ub expressions in the presence of curcumin (10–15 µM). Ub and EGFR levels were measured by Western blotting.</p
<p>(A) Total RNA from Pan02 tumor xenografts were subjected to Real time PCR. Curcumin treatment res...
<p>(A) Curcumin inhibits proliferation of esophageal cancer cells. Cells were incubated with increas...
<p>NRK-52E cells were incubated with curcumin at the indicated dose for 12 hours followed by treatme...
<p>(A) MTT assay results showed susceptibility of gefitinib in all six lung adenocarcinoma cell line...
<p>(A) Western blotting analysis the gefitinib-resistant relative proteins EGFR, AKT, c-MET, cyclin ...
<p>(A) Western blot analysis. (B, C) qRT-PCR analysis. (A) SAS cells. (B, C) SAS cells (Upper) and H...
<p>(A) MTT assay results showed curcumin enhanced the anti-proliferative effect of gefitinib in CL1-...
Background: Non-small cell lung cancer (NSCLC) patients with L858R or exon 19 deletion mutations in ...
<p>(A) Caspase-Glo 3/7 assay analysis showing gefitinib induced caspase 3/7 activity in the dose-dep...
Curcumin, a natural compound present in turmeric, possessing both anti-inflammatory and antioxidant ...
AbstractEpidermal growth factor receptor (EGFR) is an effective molecular target of anti-cancer ther...
<p>(A) HK-2 cells were stimulates with TGF-β1 (2.5 ng/ml ) for the indicated times, and the phosphor...
Curcumin (1) down-regulates the expression as well as phosphorylation of epidermal growth factor rec...
Curcumin () down-regulates the expression as well as phosphorylation of epidermal growth factor rece...
<p>Curcumin enhances the antitumor effects of gefitinib on lung adenocarcinoma are hypothesized to o...
<p>(A) Total RNA from Pan02 tumor xenografts were subjected to Real time PCR. Curcumin treatment res...
<p>(A) Curcumin inhibits proliferation of esophageal cancer cells. Cells were incubated with increas...
<p>NRK-52E cells were incubated with curcumin at the indicated dose for 12 hours followed by treatme...
<p>(A) MTT assay results showed susceptibility of gefitinib in all six lung adenocarcinoma cell line...
<p>(A) Western blotting analysis the gefitinib-resistant relative proteins EGFR, AKT, c-MET, cyclin ...
<p>(A) Western blot analysis. (B, C) qRT-PCR analysis. (A) SAS cells. (B, C) SAS cells (Upper) and H...
<p>(A) MTT assay results showed curcumin enhanced the anti-proliferative effect of gefitinib in CL1-...
Background: Non-small cell lung cancer (NSCLC) patients with L858R or exon 19 deletion mutations in ...
<p>(A) Caspase-Glo 3/7 assay analysis showing gefitinib induced caspase 3/7 activity in the dose-dep...
Curcumin, a natural compound present in turmeric, possessing both anti-inflammatory and antioxidant ...
AbstractEpidermal growth factor receptor (EGFR) is an effective molecular target of anti-cancer ther...
<p>(A) HK-2 cells were stimulates with TGF-β1 (2.5 ng/ml ) for the indicated times, and the phosphor...
Curcumin (1) down-regulates the expression as well as phosphorylation of epidermal growth factor rec...
Curcumin () down-regulates the expression as well as phosphorylation of epidermal growth factor rece...
<p>Curcumin enhances the antitumor effects of gefitinib on lung adenocarcinoma are hypothesized to o...
<p>(A) Total RNA from Pan02 tumor xenografts were subjected to Real time PCR. Curcumin treatment res...
<p>(A) Curcumin inhibits proliferation of esophageal cancer cells. Cells were incubated with increas...
<p>NRK-52E cells were incubated with curcumin at the indicated dose for 12 hours followed by treatme...